Raw deidentified data used to conduct this analysis.

Each row corresponds to a trial participant. The dataset includes 14 columns: Enrollment date; Age; Sex; BMI; On ART; Years on ART; Prior TB; One-way travel time to clinic (hours); Education level (none, primary, secondary, postsecondary (university or graduate school), or vocational/tertiary); Employment status (not employed, self-employed, temporary/informal work, hired worker, or student); MPI category (severely multidimensionally poor, multidimensionally poor but not severely, not poor but vulnerable to becoming poor, or not poor nor vulnerable to becoming poor); Outcome date; Outcome reason (completed 3HP treatment, missed 6 or more doses, stopped 3HP due to a documented AE, never initiated 3HP treatment, pregnancy, new medication with 3HP drug–drug interaction, other reason, or specify (died in a motor vehicle accident); Primary outcome (≥11 of 12 doses within 16 weeks of randomization). AE, adverse event; ART, antiretroviral therapy; BMI, body mass index; MPI, Multidimensional Poverty Index; TB, tuberculosis.
(CSV)